230 related articles for article (PubMed ID: 21454703)
1. Heme interacts with c1q and inhibits the classical complement pathway.
Roumenina LT; Radanova M; Atanasov BP; Popov KT; Kaveri SV; Lacroix-Desmazes S; Frémeaux-Bacchi V; Dimitrov JD
J Biol Chem; 2011 May; 286(18):16459-69. PubMed ID: 21454703
[TBL] [Abstract][Full Text] [Related]
2. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q.
Jiang HX; Siegel JN; Gewurz H
J Immunol; 1991 Apr; 146(7):2324-30. PubMed ID: 2005402
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q.
Nauta AJ; Bottazzi B; Mantovani A; Salvatori G; Kishore U; Schwaeble WJ; Gingras AR; Tzima S; Vivanco F; Egido J; Tijsma O; Hack EC; Daha MR; Roos A
Eur J Immunol; 2003 Feb; 33(2):465-73. PubMed ID: 12645945
[TBL] [Abstract][Full Text] [Related]
4. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
Duvall MR; Hwang HY; Boackle RJ
Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
[TBL] [Abstract][Full Text] [Related]
5. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region.
McGrath FD; Brouwer MC; Arlaud GJ; Daha MR; Hack CE; Roos A
J Immunol; 2006 Mar; 176(5):2950-7. PubMed ID: 16493053
[TBL] [Abstract][Full Text] [Related]
6. Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement System.
Laursen NS; Pedersen DV; Gytz H; Zarantonello A; Bernth Jensen JM; Hansen AG; Thiel S; Andersen GR
Front Immunol; 2020; 11():1504. PubMed ID: 32849513
[TBL] [Abstract][Full Text] [Related]
7. Complement C1q-target proteins recognition is inhibited by electric moment effectors.
Roumenina L; Bureeva S; Kantardjiev A; Karlinsky D; Andia-Pravdivy JE; Sim R; Kaplun A; Popov M; Kishore U; Atanasov B
J Mol Recognit; 2007; 20(5):405-15. PubMed ID: 17929239
[TBL] [Abstract][Full Text] [Related]
8. Specific inhibition of the classical complement pathway by C1q-binding peptides.
Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of activation of the classical pathway of complement by human neutrophil defensins.
van den Berg RH; Faber-Krol MC; van Wetering S; Hiemstra PS; Daha MR
Blood; 1998 Nov; 92(10):3898-903. PubMed ID: 9808583
[TBL] [Abstract][Full Text] [Related]
10. Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.
Lilienthal GM; Rahmöller J; Petry J; Bartsch YC; Leliavski A; Ehlers M
Front Immunol; 2018; 9():958. PubMed ID: 29867943
[TBL] [Abstract][Full Text] [Related]
11. Characterization of C1q in teleosts: insight into the molecular and functional evolution of C1q family and classical pathway.
Hu YL; Pan XM; Xiang LX; Shao JZ
J Biol Chem; 2010 Sep; 285(37):28777-86. PubMed ID: 20615881
[TBL] [Abstract][Full Text] [Related]
12. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
Jiang H; Robey FA; Gewurz H
J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
[TBL] [Abstract][Full Text] [Related]
13. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
Mihlan M; Blom AM; Kupreishvili K; Lauer N; Stelzner K; Bergström F; Niessen HW; Zipfel PF
FASEB J; 2011 Dec; 25(12):4198-210. PubMed ID: 21856781
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.
Gaboriaud C; Juanhuix J; Gruez A; Lacroix M; Darnault C; Pignol D; Verger D; Fontecilla-Camps JC; Arlaud GJ
J Biol Chem; 2003 Nov; 278(47):46974-82. PubMed ID: 12960167
[TBL] [Abstract][Full Text] [Related]
15. A recombinant homotrimer, composed of the alpha helical neck region of human surfactant protein D and C1q B chain globular domain, is an inhibitor of the classical complement pathway.
Kishore U; Strong P; Perdikoulis MV; Reid KB
J Immunol; 2001 Jan; 166(1):559-65. PubMed ID: 11123337
[TBL] [Abstract][Full Text] [Related]
16. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
17. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
18. Solid-phase classical complement activation by C-reactive protein (CRP) is inhibited by fluid-phase CRP-C1q interaction.
Sjöwall C; Wetterö J; Bengtsson T; Askendal A; Almroth G; Skogh T; Tengvall P
Biochem Biophys Res Commun; 2007 Jan; 352(1):251-8. PubMed ID: 17113035
[TBL] [Abstract][Full Text] [Related]
19. Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen.
Wang G; de Jong RN; van den Bremer ET; Beurskens FJ; Labrijn AF; Ugurlar D; Gros P; Schuurman J; Parren PW; Heck AJ
Mol Cell; 2016 Jul; 63(1):135-45. PubMed ID: 27320199
[TBL] [Abstract][Full Text] [Related]
20. Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q.
Chen FH; Arya SK; Rinfret A; Isenman DE; Shulman MJ; Painter RH
J Immunol; 1997 Oct; 159(7):3354-63. PubMed ID: 9317134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
